- Report
- May 2025
- 50 Pages
Global
From €2424EUR$2,650USD£2,063GBP
- Report
- May 2025
- 50 Pages
Global
From €2424EUR$2,650USD£2,063GBP
Phenoxybenzamine is a drug used in the treatment of cardiovascular diseases. It is a non-selective alpha-adrenergic antagonist, meaning it blocks the action of the hormone adrenaline on the body's alpha-adrenergic receptors. This helps to reduce blood pressure and improve blood flow. It is used to treat hypertension, angina, and other cardiovascular conditions. It is also used to treat pheochromocytoma, a rare tumor of the adrenal glands. Phenoxybenzamine is available in both oral and injectable forms.
Phenoxybenzamine is a widely used drug in the cardiovascular market. It is used to treat a variety of conditions, from hypertension to pheochromocytoma. It is generally well-tolerated and has few side effects.
Some companies in the Phenoxybenzamine market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more